| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/10/2013 | US20130011849 Methods for Detection of Biological Substances |
| 01/10/2013 | US20130011847 Estrogen receptors and methods of use |
| 01/10/2013 | US20130011845 Microrna regulating the insulin signaling pathway, and method for screening material for controlling the action of a target thereof |
| 01/10/2013 | US20130011844 Novel Biomarker Indicative of Ischemic Brain Injury and Its Use |
| 01/10/2013 | US20130011839 Methods for the Reduction of Stutter in Microsatellite Amplification |
| 01/10/2013 | US20130011837 Assays for Affinity Profiling of Nucleic Acid Binding Proteins |
| 01/10/2013 | US20130011835 Compositions and methods for treating inflammation |
| 01/10/2013 | US20130011830 Fast results hybrid capture assay and system |
| 01/10/2013 | US20130011827 Methods and kits for decreasing interferences in plasma or serum containing assay samples of specific binding assays |
| 01/10/2013 | US20130011826 Methods and kits for decreasing interferences from leukocytes in specific binding assays |
| 01/10/2013 | US20130011497 Method of treatment and screening method |
| 01/10/2013 | US20130011496 Cancer testis antigens as biomarkers in non-small cell lung cancer |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011427 Flavivirus species-specific peptide tags for vaccine and diagnostic use |
| 01/10/2013 | US20130011414 Broadly cross-reactive hiv-1-specific antibodies for prevention and treatment of hiv |
| 01/10/2013 | US20130011409 Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 |
| 01/10/2013 | US20130011406 Anti-kit antibodies and uses thereof |
| 01/10/2013 | US20130011404 Methods and Compositions for Regulating Musashi Function |
| 01/10/2013 | US20130011402 Compositions and methods for the diagnosis and treatment of tumor |
| 01/10/2013 | US20130011401 Soluble proteins for use as therapeutics |
| 01/10/2013 | US20130011389 Compositions and methods for treating coagulation related disorders |
| 01/10/2013 | US20130011380 Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming |
| 01/10/2013 | US20130011371 ESTABLISHMENT OF PATIENT- OR PERSON- SPECIFIC CARDIAC MYOCYTE CELL LINES FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (iPSCs) |
| 01/10/2013 | US20130011335 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and SRC |
| 01/10/2013 | US20130011299 Apparatus for Testing Catalyst |
| 01/10/2013 | US20130009781 Anti-terrorism water quality monitoring system |
| 01/10/2013 | US20130008802 Method for operating a measurement for a sample on an electrochemical test strip |
| 01/10/2013 | US20130008786 Sensor chip and storage method thereof |
| 01/10/2013 | US20130008236 Method for standardizing measured results in a system for measuring thrombocyte function |
| 01/10/2013 | US20130008235 Composition of multiphase flow |
| 01/10/2013 | US20130008228 Variable gas source gas exchange system |
| 01/10/2013 | DE102011106523A1 Prüfgerät und Verfahren zur Kalibrierung eines Prüfgeräts Instrument and method for calibrating a tester |
| 01/10/2013 | DE102011080765A1 Überwachung der Funktionalität eines Konverters eines Atemanalysegerätes Monitoring of the functionality of a converter of a breath analysis device |
| 01/10/2013 | DE102008060332B4 Verfahren zum Sortieren von mindestens einem Partikel mit einer mikrofluidischen Sortiervorrichtung mit optischer Pinzette A method of sorting at least one particle with a microfluidic sorting device with optical tweezers |
| 01/10/2013 | CA2844144A1 Rna-yy1 interactions |
| 01/10/2013 | CA2841793A1 Device for measurement coupled with water parameters of soil |
| 01/10/2013 | CA2841131A1 Spectroscopic analysis of oil sands ore face for real time ore blend management |
| 01/10/2013 | CA2840971A1 Assay |
| 01/10/2013 | CA2840949A1 Reagent storage on a droplet actuator |
| 01/10/2013 | CA2840868A1 Hcv genotype 4 replicons |
| 01/10/2013 | CA2840828A1 Hcv genotype 3 replicons |
| 01/10/2013 | CA2840812A1 Systems and methods for clinical evaluation of psychiatric disorders |
| 01/10/2013 | CA2840687A1 Discovery of a somatic mutation in myd88 gene in lymphoplasmacytic lymphoma |
| 01/10/2013 | CA2840590A1 Method for increasing specificity of diagnostic tests for autoimmune diseases |
| 01/10/2013 | CA2840424A1 Regulatory t cells and methods of identifying, obtaining and using to treat immuno-based disorders |
| 01/10/2013 | CA2840232A1 Assays for detecting neutralizing autoantibodies to biologic therapy with tnf alpha |
| 01/10/2013 | CA2840226A1 Method of analyzing cardiovascular disorders and uses thereof |
| 01/10/2013 | CA2840126A1 Centrifugal microfluidic platform |
| 01/10/2013 | CA2839388A1 Method and apparatus for estimation of heat value |
| 01/10/2013 | CA2839001A1 Checking unit and method for calibrating a checking unit |
| 01/10/2013 | CA2838819A1 Methods for predicting mammalian embryo viability |
| 01/10/2013 | CA2835234A1 Sampling procedure for polymer-based solutions used in underground formations |
| 01/09/2013 | EP2544141A1 Diagnostic information distribution device and pathology diagnosis system |
| 01/09/2013 | EP2544009A2 Microfluidic device comprising microchannel where protrusions are formed on bottom surface |
| 01/09/2013 | EP2544008A1 Measurement of protein using inclusion body dry weight |
| 01/09/2013 | EP2544007A1 Biomarker of renal impairment |
| 01/09/2013 | EP2544006A1 Biomarker combinations for colorectal cancer |
| 01/09/2013 | EP2544005A1 Gastric cancer marker, and method for detecting gastric cancer |
| 01/09/2013 | EP2544004A1 Gastric cancer marker, and method for detecting gastric cancer |
| 01/09/2013 | EP2544003A1 Caveolin-1 in tumor-associated fibroblasts as biomarker for tumor progression |
| 01/09/2013 | EP2544002A1 Polymer including group having at least two hydroxyls or zwitterionic group and use thereof |
| 01/09/2013 | EP2544001A2 Measuring multiple analytes over a broad range of concentrations using optical diffraction |
| 01/09/2013 | EP2544000A1 Breath alcohol measurement device |
| 01/09/2013 | EP2543999A1 Cell detection method and cell detection system |
| 01/09/2013 | EP2543998A1 Method for standardising measurement results in a system for measuring thrombocyte function |
| 01/09/2013 | EP2543997A1 Method and apparatus for estimation of heat value |
| 01/09/2013 | EP2543991A1 Uracil-specific fluorescence detection reaction and method for examining dihydropyrimidine dehydrogenase deficiency |
| 01/09/2013 | EP2543988A1 Spectrophotometer, spectrophotometer tool, spectrophotometric method, and program |
| 01/09/2013 | EP2543706A2 Stabilizer of color former and use thereof |
| 01/09/2013 | EP2543315A1 Pressure-measuring system for medical ventilator |
| 01/09/2013 | EP2543311A1 System and method for excitation generation in soft-field tomography |
| 01/09/2013 | EP2542898A1 Progastrin and liver pathologies |
| 01/09/2013 | EP2542897A1 Use of halogenated cyanocinnamic acid derivatives as matrices in maldi mass spectrometry |
| 01/09/2013 | EP2542896A1 Kidney prognostic assay |
| 01/09/2013 | EP2542895A1 Increase of myeloid microvesicles in the cerebrospinal fluid as biomarker of microglia/macrophage activation in neurological disorders |
| 01/09/2013 | EP2542894A1 Il-6 detection based early diagnosis and prediction of systemic inflammatory response syndrome and sepsis in asymptomatic patients |
| 01/09/2013 | EP2542893A2 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 01/09/2013 | EP2542892A2 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 01/09/2013 | EP2542891A2 Ultra-sensitive detection of molecules or particles using beads or other capture objects |
| 01/09/2013 | EP2542890A1 Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
| 01/09/2013 | EP2542889A1 Ligand guanidinyl functionalized polymers |
| 01/09/2013 | EP2542888A2 Method and kit for isolating target cell |
| 01/09/2013 | EP2542887A1 Test strip for the detection of equol |
| 01/09/2013 | EP2542886A1 System and method for monitoring at least one blood parameter |
| 01/09/2013 | EP2542885A1 Analyte quantification using flow induced dispersion analysis |
| 01/09/2013 | EP2542702A1 A method to predict the pattern of locomotion in horses |
| 01/09/2013 | EP2542701A1 Biomarkers of osteoarthritis |
| 01/09/2013 | EP2542700A2 Integrated assay that combines flow-cytometry and multiplexed hpv genotype identification |
| 01/09/2013 | EP2542696A1 Biomarkers for theranostics |
| 01/09/2013 | EP2542692A1 Method for selecting patients for treatment with an egfr inhibitor |
| 01/09/2013 | EP2542689A1 Method for isolating target cells |
| 01/09/2013 | EP2542687A1 Involvement of androgen/androgen receptor pathway in fabry disease |
| 01/09/2013 | EP2542643A2 Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same |
| 01/09/2013 | EP2542580A1 Antibodies against phosphorylcholine in combination therapy with biologic agents |
| 01/09/2013 | EP2542574A2 Method for producing soluble recombinant interferon protein without denaturing |
| 01/09/2013 | EP2542571A1 Oligomer-specific amyloid beta epitope and antibodies |
| 01/09/2013 | EP2542263A2 Ep1 inhibition |
| 01/09/2013 | EP2542253A1 Modulation of intracellular signaling |
| 01/09/2013 | EP2542252A1 Hiv-1 envelope based fragments |
| 01/09/2013 | EP2542151A1 System for determining treatment-related data for the administration of drugs to patients to be treated taking into account important individual factors |